Ico Therapeutics, Inc.

Ordinary Shares International Reporting
OTCQX International OTCQX Advisor: Troutman Sanders LLP
Verified Company Profile 8/04/2016
Contact Info
  • 760-777 Hornby Street
  • Vancouver, BC V6Z 1S4
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Sep 30, 2016 Quarterly Report
CIK 0001421642
Fiscal Year End 12/31
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: British Columbia, Canada
Year of Inc. 2005
Employees 5 a/o Jul 31, 2016
Company Officers/Contacts
Andrew Rae President, CEO
John Meekison CFO
Peter Hnik Chief Med. Officer
Company Directors
William Jarosz
Susan Koppy
John Meekison
Andrew Rae
Service Providers
OTCQX Advisor
Troutman Sanders LLP
875 Third Avenue
New York, NY, 10022

Accounting/Auditing Firm
PricewaterhouseCoopers LLP
250 Howe Street
Suite 700
Vancouver, BC, V6C 3S7

Legal Counsel
Blakes, Cassels & Graydon LLP
595 Burnard Street
PO Box 49314
Vancouver, BC, V7X 1L3

Investor Relations Firm
Not Available
ICOTF Security Details
Share Structure
Market Value1 $4,146,874 a/o Dec 08, 2016
Authorized Shares Unlimited a/o Mar 31, 2016
Outstanding Shares 84,457,713 a/o Sep 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 78,985,114 a/o Jun 01, 2015
Par Value No Par Value
Shareholders of Record Not Available
Non US Stock Exchange Listing
ICO - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 19,500 (0%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security